The Ukrainian pharmaceutical company Lekhim plans to launch phase one of its plant in Uzbekistan in 2023 to produce ampoule.

Speaking to Interfax-Ukraine, the Chairman of the Supervisory Board of the Lekhim Group, Valeriy Pechaev said, “In 2020, we created the Lekhim enterprise in Tashkent to sell domestic medicines and to build a production facility in Uzbekistan. Since 2020, Lekhim has invested $2.5 million in this project, the total investment to 2023 will be $10-12 million, and the total cost of the project is about $ 40 million. Lekhim is financing the project from its own funds and plans to work with the EBRD in the later stages of project completion.